/Lists

Biotech Series A Investors & VC Firms

1626 firms in this list, with a median first check of $500K. 369 of them lead rounds. Generated from verified public data and updated continuously.

AlleyCorp
New YorkPre-Seed–Series A$1M – $5M
29 people
Longitude Capital
Menlo ParkSeries A–Late Stage$10M – $30M
61 people
Bayern Kapital
LandshutSeed–Late Stage$275K – $55M
46 people
Elaia
ParisSeed–Series C$108K – $1.6M
45 people
Third Rock Ventures
BostonSeed–Series C$100K – $5M
62 people
Oxford Science Enterprises
OxfordPre-Seed–Growth$63.5K – $31.8M
71 people
Bantam Group
WestwoodPre-Seed–Series A
1 person
Golden Seeds
FlushingPre-Seed–Series A$250K – $2M
60 people
Vivo Capital
Palo AltoSeed–Late Stage$10M – $50M
58 people
Addor Capital
NanjingSeed–Series B
44 people
Versant Ventures
San FranciscoSeed–Late Stage$250K – $5M
55 people
Pillar VC
BostonPre-Seed–Series A$50K – $4M
62 people
NVIDIA
Santa ClaraPre-Seed–Growth
17 people
Polaris Partners
BostonSeed–Growth$500K – $5M
45 people
HOF Capital
New YorkPre-Seed–Growth$500K – $10M
45 people
Obvious Ventures
San FranciscoPre-Seed–Late Stage$250K – $6M
40 people
Cota Capital
San FranciscoPre-Seed–Series A
26 people
Wing
Palo AltoPre-Seed–Series B$200K – $20M
22 people
IMM Investment Japan
TokyoSeed–Growth
21 people
5AM Ventures
San FranciscoSeed–Late Stage$100K – $4M
41 people
Nippon Venture Capital
TokyoPre-Seed–Growth$300K – $5M
29 people
Flucas Ventures
JupiterSeed–Series A$100K – $5M
1 person
Portfolia
San MateoSeed–Series B
58 people
Cultivation Capital
St. LouisSeed–Series B$100K – $3.5M
37 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.